RS Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$98.4M Sell
1,322,074
-140,736
-10% -$10.4M 1.01% 13
2016
Q1
$97.7M Sell
1,462,810
-284,027
-16% -$17.3M 0.97% 16
2015
Q4
$118M Sell
1,746,837
-464,069
-21% -$28.7M 1.06% 16
2015
Q3
$118M Buy
2,210,906
+635,221
+40% +$38.5M 1.05% 11
2015
Q2
$99.2M Sell
1,575,685
-327,878
-17% -$17.9M 0.85% 20
2015
Q1
$91.6M Sell
1,903,563
-389,769
-17% -$14.9M 0.82% 27
2014
Q4
$76.1M Sell
2,293,332
-100,965
-4% -$3.28M 0.68% 35
2014
Q3
$70.2M Buy
2,394,297
+162,624
+7% +$5.4M 0.65% 45
2014
Q2
$86.7M Buy
2,231,673
+271,994
+14% +$11M 0.73% 30
2014
Q1
$82.2M Sell
1,959,679
-148,423
-7% -$6.19M 0.48% 52
2013
Q4
$69.2M Buy
2,108,102
+1,160,136
+122% +$37.8M 0.42% 65
2013
Q3
$25.6M Buy
+947,966
New +$26.7M 0.17% 158

Other funds holding LGND